Paper3553733
Biology of tumor progression in human melanocytes.
Herlyn M and 5 others. Lab Invest, 1987. Cited by 263 papers, by iCite.
Cite this record
ConductScience Library. Biology of tumor progression in human melanocytes. Papers, record 3553733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3553733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanocytes | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Antigens, Neoplasm | |
| Cell Differentiation | |
| Cells, Cultured | |
| Chromosome Aberrations | |
| Chromosome Disorders | |
| Growth Substances | |
| Humans | |
| Karyotyping | |
| Nevus |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-10815 | NCI NIH HHS | United States | P01CA010815 | PubMed and NIH | NIH RePORTER |
| CA-16520 | NCI NIH HHS | United States | P01CA016520 | PubMed and NIH | NIH RePORTER |
| CA-25874 | NCI NIH HHS | United States | P01CA025874 | PubMed and NIH | NIH RePORTER |
| P30CA010815 | NIH | NIH RePORTER | |||
| P30CA016520 | NIH | NIH RePORTER |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41845929 | Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553-Patient Single-Center Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/41845929 | PubMed |
| 38713345 | Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D3 or eldecalcitol. | In Vitro Cell Dev Biol Anim | 2024 | https://conductscience.org/library/papers/38713345 | PubMed |
| 34072393 | Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34072393 | PubMed |
| 33430277 | Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33430277 | PubMed |
| 32712709 | Focal aggregates of normal or near normal uveal melanocytes (FANNUMs) in the choroid: a distinct clinical and histopathological entity? | Graefes Arch Clin Exp Ophthalmol | 2021 | https://conductscience.org/library/papers/32712709 | PubMed |
| 28604751 | Melanocytic nevi and melanoma: unraveling a complex relationship. | Oncogene | 2017 | https://conductscience.org/library/papers/28604751 | PubMed |
| 21386910 | Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. | PLoS One | 2011 | https://conductscience.org/library/papers/21386910 | PubMed |
| 21317876 | IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. | Mod Pathol | 2011 | https://conductscience.org/library/papers/21317876 | PubMed |
| 18353142 | Cancer stem cells and human malignant melanoma. | Pigment Cell Melanoma Res | 2008 | https://conductscience.org/library/papers/18353142 | PubMed |
| 17912546 | The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. | Pflugers Arch | 2008 | https://conductscience.org/library/papers/17912546 | PubMed |
| 16611417 | Melanocyte transformation associated with substrate adhesion impediment. | Neoplasia | 2006 | https://conductscience.org/library/papers/16611417 | PubMed |
| 15846299 | Flexible, actin-based ridges colocalise with the beta1 integrin on the surface of melanoma cells. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15846299 | PubMed |
| 15375381 | Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. | Cancer Gene Ther | 2005 | https://conductscience.org/library/papers/15375381 | PubMed |
| 12693720 | Biological evaluation of an antibiotic DC-81-indole conjugate agent in human melanoma cell lines. | Kaohsiung J Med Sci | 2003 | https://conductscience.org/library/papers/12693720 | PubMed |
| 11498770 | Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. | Cancer Gene Ther | 2001 | https://conductscience.org/library/papers/11498770 | PubMed |
| 11355947 | 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11355947 | PubMed |
| 10487833 | Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10487833 | PubMed |
| 9811334 | Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9811334 | PubMed |
| 8878460 | Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8878460 | PubMed |
| 8613432 | Expression of thymidine phosphorylase in human gastric carcinoma. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8613432 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3553733
GET https://conductscience.org/api/papers/v1/3553733/cited_by?page=2